LDFO
CELU icon

Louis-Dreyfus Family Office’s Celularity CELU Stock Holding History

Louis-Dreyfus Family Office’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$1.66M Hold
72,004
– – 2.57% 3
2022
Q2 		$2.45M Hold
72,004
– – 3.29% 3
2022
Q1 		$6.27M Hold
72,004
– – 7.5% 3
2021
Q4 		$3.69M Buy
+72,004
New +$4.6M 4.5% 3

Other funds holding CELU

SIC
Starr International Company Zug, Switzerland $19.9M AUM 39.69% 1-Year Est. Return
CVSC
C.V. Starr & Co New York $192M AUM 35.69% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BRF
B. Riley Financial Los Angeles, California $456M AUM 896.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Louis-Dreyfus Family Office's CELU Position: Q3 2022 in Review

Louis-Dreyfus Family Office held its Celularity (CELU) position steady in Q3 2022 at 72,004 shares worth $1.66M. The position accounts for 2.57% of the portfolio, ranked #3.

Louis-Dreyfus Family Office first reported a position in CELU in Q4 2021 and has held it in 4 quarters since. The position peaked at $6.27M in Q1 2022. 72 funds tracked by Wall St. Rank hold CELU as of Q3 2022.

  • Louis-Dreyfus Family Office held 72,004 shares of Celularity worth $1.66M as of Q3 2022.
  • Louis-Dreyfus Family Office left its Celularity share count unchanged in Q3 2022.
  • Celularity made up 2.57% of Louis-Dreyfus Family Office's portfolio in Q3 2022, its #3 holding.
  • Louis-Dreyfus Family Office first reported a position in Celularity in Q4 2021 and has held it in 4 quarters since.
  • Louis-Dreyfus Family Office's Celularity position peaked at $6.27M in Q1 2022.
  • 72 funds tracked by Wall St. Rank held Celularity as of Q3 2022.

Based on Louis-Dreyfus Family Office's 13F filing for Q3 2022, filed 10 Nov 2022.